Om avsnittet

Welcome to ImmunoLOGIK. In this episode, we have Enikö Sonkoly and Alexander Egeberg, both dermatology specialists, discussing prevention and its impact on immune-mediated inflammatory diseases like psoriasis, psoriatic arthritis, and inflammatory bowel disease. Discussed articles: • IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE) • Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study Questions addressed: • What is the definition of prevention? • Is it currently possible to approach clinical thinking in a preventive manner, and if so, how? • What are the preventive measures for psoriatic arthritis? • What is the evidence supporting the use of early intervention and tight control strategies in the management of immune-mediated inflammatory diseases • What are the challenges in implementing preventive measures? Feedback, suggestions for discussion topics, and listener questions can be sent to immunoLOGIK@its.jnj.com For more information Janssen Medical Cloud ImmunoLOGIK is produced by Janssen. CP-394004